ALB and hydrops fetalis: Inflammatory biomarkers, such as high-sensitivity C-reactive protein (hsCRP), fibrinogen (FIB), albumin, erythrocyte sedimentation rate (ESR), and indices within the complete blood cell count (including white blood cells [WBC], neutrophils, lymphocytes, and red blood cell distribution width [RDW]), have been identified as potential predictors of adverse outcomes in patients with CAD or HF (6–10).